{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T18:15:33Z","timestamp":1648836933573},"reference-count":34,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.ejphar.2005.08.040","type":"journal-article","created":{"date-parts":[[2005,10,11]],"date-time":"2005-10-11T11:22:58Z","timestamp":1129029778000},"page":"38-46","source":"Crossref","is-referenced-by-count":7,"title":["Antinociceptive, brain-penetrating derivatives related to improgan, a non-opioid analgesic"],"prefix":"10.1016","volume":"522","author":[{"given":"Lindsay B.","family":"Hough","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia W.","family":"Nalwalk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixing","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantina","family":"Svokos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark P.","family":"Wentland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Jos\u00e9","family":"Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2005.08.040_bib1","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/0006-2952(93)90606-W","article-title":"Cimetidine-induced seizures in mice. Antagonism by some GABAergic agents","volume":"46","author":"Amabeoku","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.08.040_bib2","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1476-5381.1985.tb11083.x","article-title":"Pharmacological basis for the induction of gastric carcinoid tumours in the rat by loxtidine, an insurmountable histamine H2-receptor blocking drug","volume":"85","author":"Brittain","year":"1985","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.08.040_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1476-5381.1988.tb11406.x","article-title":"Zolantidine (SK&F 95282) is a potent selective brain-penetrating histamine H2-receptor antagonist","volume":"93","author":"Calcutt","year":"1988","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.08.040_bib4","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.lfs.2004.05.020","article-title":"Effects of cimetidine-like drugs on recombinant GABAA receptors","volume":"75","author":"Cannon","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2005.08.040_bib5","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0091-3057(79)90336-8","article-title":"Simple cannula for repeated intracerebral drug administration in rats","volume":"10","author":"Crane","year":"1979","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2005.08.040_bib6","first-page":"74","article-title":"A method for determining loss of pain sensation","volume":"72","author":"D'Amour","year":"1941","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.08.040_bib7","first-page":"385","article-title":"Synthetic analgesics, II dithienylbutenyl and dithienylbutylamines","volume":"107","author":"Eddy","year":"1953","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.08.040_bib8","series-title":"Pharmacology of Histamine Receptors","first-page":"10","article-title":"Chemistry and structure\u2013activity relationships of drugs acting at histamine receptors","author":"Ganellin","year":"1982"},{"key":"10.1016\/j.ejphar.2005.08.040_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00421114","article-title":"Studies on the effects of histaminergic agents on seizure susceptibility in mice","volume":"46","author":"Gerald","year":"1976","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.ejphar.2005.08.040_bib10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0028-3908(88)90143-8","article-title":"Effects of zolantidine a brain-penetrating H2-receptor antagonist, on naloxone-sensitive and naloxone-resistant analgesia","volume":"27","author":"Gogas","year":"1988","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2005.08.040_bib11","first-page":"262","article-title":"Inhibition of naloxone-resistant antinociception by centrally-administered H2 antagonists","volume":"248","author":"Gogas","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.08.040_bib12","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0091-3057(86)90181-4","article-title":"Cimetidine penetrates brain and inhibits non-opiate footshock-induced analgesia","volume":"24","author":"Hough","year":"1986","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2005.08.040_bib13","first-page":"1534","article-title":"Novel qualitative structure\u2013activity relationships for the antinociceptive actions of H2 antagonists, H3 antagonists and derivatives","volume":"283","author":"Hough","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.08.040_bib14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0006-8993(00)02776-1","article-title":"Improgan, a cimetidine analog, induces morphine-like antinociception in opioid receptor-knockout mice","volume":"880","author":"Hough","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2005.08.040_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0091-3057(99)00187-2","article-title":"Antinociceptive activity of derivatives of improgan and burimamide","volume":"65","author":"Hough","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2005.08.040_bib16","series-title":"Histamine Research in the New Millenium","first-page":"237","article-title":"A third legacy for burimamide: discovery and characterization of improgan and a new class of non-opioid analgesics derived from histamine antagonists","author":"Hough","year":"2001"},{"key":"10.1016\/j.ejphar.2005.08.040_bib17","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/S0024-3205(01)01080-3","article-title":"Significance of GABAergic systems in the action of improgan, a non-opioid analgesic","volume":"68","author":"Hough","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2005.08.040_bib18","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/jpet.102.036251","volume":"303","author":"Hough","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.08.040_bib19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1021\/jm00299a003","article-title":"Structure\u2013activity correlations of morphine-like analgetics based on efficiencies following intravenous and intraventricular application","volume":"13","author":"Kutter","year":"1970","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2005.08.040_bib20","first-page":"500","article-title":"Characterization of the antinociceptive properties of cimetidine and a structural analog","volume":"276","author":"Li","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.08.040_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3727\/107156997819566091","article-title":"SKF92374, a cimetidine analog, produces mechanical and thermal antinociception in the absence of motor impairment","volume":"3","author":"Li","year":"1997","journal-title":"Analgesia"},{"key":"10.1016\/j.ejphar.2005.08.040_bib22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0006-8993(96)01288-7","article-title":"Effects of naltrexone and histamine antagonists on the antinociceptive activity of the cimetidine analog SKF92374 in rats","volume":"748","author":"Li","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2005.08.040_bib23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0006-8993(03)02572-1","article-title":"Improgan antinociception does not require neuronal histamine or histamine receptors","volume":"974","author":"Mobarakeh","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2005.08.040_bib24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.pbb.2005.01.006","article-title":"Absence of 5-HT3 and cholinergic mechanisms in improgan antinociception","volume":"80","author":"Nalwalk","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2005.08.040_bib25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.brainres.2004.06.066","article-title":"Activation of brain stem nuclei by improgan, a non-opioid analgesic","volume":"1021","author":"Nalwalk","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2005.08.040_bib26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000137972","article-title":"Antinociceptive effect of centrally administered cimetidine and dimaprit in the rat","volume":"28","author":"Netti","year":"1984","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejphar.2005.08.040_bib34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1254\/jjp.42.229","article-title":"Pharmacological studies of 2-(3-(3-(1-piperidinylmethyl)-phenoxy)propylamino)-4 (3H)-quinazolinone (NO-794), a new histamine H2-receptor antagonist","volume":"42","author":"Oshita","year":"1986","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.08.040_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1476-5381.1995.tb16319.x","article-title":"JB-9322, a new selective histamine H2-receptor antagonist with potent gastric mucosal protective properties","volume":"115","author":"Palacios","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.08.040_bib28","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.ejphar.2005.08.040_bib29","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/clpt.1981.104","article-title":"Age, disease, and cimetidine disposition in healthy subjects and chronically ill patients","volume":"29","author":"Schentag","year":"1981","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2005.08.040_bib30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1006\/taap.1996.0038","article-title":"Neurotoxic convulsions induced by histamine H2 receptor antagonists in mice","volume":"136","author":"Shimokawa","year":"1996","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.08.040_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0006-8993(01)03191-2","article-title":"A role for spinal, but not supraspinal, alpha2 adrenergic receptors in the actions of improgan, a powerful, non-opioid analgesic","volume":"921","author":"Svokos","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2005.08.040_bib32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1055\/s-2002-33193","article-title":"H(2)-histamine antagonist (famotidine) induced adverse CNS reactions with long-standing secondary mania and epileptic seizures","volume":"35","author":"von Einsiedel","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ejphar.2005.08.040_bib33","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1021\/jm00398a028","article-title":"Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists","volume":"31","author":"Young","year":"1988","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905008939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905008939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T12:09:17Z","timestamp":1553947757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299905008939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":34,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0014299905008939"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2005.08.040","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}